Esther Seco

Esther Seco

Auto-generated profile, based on publicly available information

Esther Seco

Instituto Cajal-CSIC, Madrid, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2017 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
LELorena Esteban‐Martínez
Lorena Esteban‐Martínez
ESElena Sierra‐Filardi
Elena Sierra‐Filardi
RMRebecca S McGreal
Rebecca S McGreal
MSMaría Salazar‐Roa
María Salazar‐Roa
Guillermo MariñoGuillermo Mariño
Guillermo Mariño
Patricia BoyaPatricia Boya
Patricia Boya

31 August 2015 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
EDElena Doménech
Elena Doménech
CMCarolina Maestre
Carolina Maestre
LELorena Esteban-Martínez
Lorena Esteban-Martínez
DPDavid Partida
David Partida
RPRosa Pascual
Rosa Pascual
MMMarcos Malumbres
Marcos Malumbres

4 May 2015 in Autophagy
Verified
Journal Article
Closed access
MMMarta Mauro-Lizcano
Marta Mauro-Lizcano
LELorena Esteban-Martínez
Lorena Esteban-Martínez
ESEsther Seco
Esther Seco
ASAna Serrano-Puebla
Ana Serrano-Puebla
LGLucia Garcia-Ledo
Lucia Garcia-Ledo
Patricia BoyaPatricia Boya
Patricia Boya
Mitochondrial autophagy, also known as mitophagy, is an autophagosome-based mitochondrial degradation process that eliminates unwanted or damaged mitochondria after cell stress. Most studies dealing with mitophagy rely on the analysis by fluorescence microscopy of mitochondrial-autophagosome colocalization. However, given the fundamental role of mitophagy in the physiology and pathology of organisms, there is an urgent need for novel quantitative methods with which to study this process. Here, we describe a flow cytometry-based approach to determine mitophagy by using MitoTracker Deep Red, a widely used mitochondria-selective probe. Used in combination with selective inhibitors it may allow for the determination of mitophagy flux. Here, we test the validity of the use of this method in cell lines and in primary cell and tissue cultures.

17 December 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MPMarta Portela
Marta Portela
VVVarun Venkataramani
Varun Venkataramani
NFNatasha Fahey-Lozano
Natasha Fahey-Lozano
ESEsther Seco
Esther Seco
MLMaría Losada-Pérez
María Losada-Pérez
SCSergio Casas
Sergio Casas
Glioblastoma (GB) is the most lethal brain tumor, and Wingless (Wg)-related integration site (WNT) pathway activation in these tumors is associated with a poor prognosis. Clinically, the disease is characterized by progressive neurological deficits. However, whether these symptoms result from direct or indirect damage to neurons is still unresolved. Using Drosophila and primary xenografts as models of human GB, we describe, here, a mechanism that leads to activation of WNT signaling (Wg in Drosophila) in tumor cells. GB cells display a network of tumor microtubes (TMs) that enwrap neurons, accumulate Wg receptor Frizzled1 (Fz1), and, thereby, deplete Wg from neurons, causing neurodegeneration. We have defined this process as “vampirization.” Furthermore, GB cells establish a positive feedback loop to promote their expansion, in which the Wg pathway activates cJun N-terminal kinase (JNK) in GB cells, and, in turn, JNK signaling leads to the post-transcriptional up-regulation and accumulation of matrix metalloproteinases (MMPs), which facilitate TMs’ infiltration throughout the brain, TMs’ network expansion, and further Wg depletion from neurons. Consequently, GB cells proliferate because of the activation of the Wg signaling target, β-catenin, and neurons degenerate because of Wg signaling extinction. Our findings reveal a molecular mechanism for TM production, infiltration, and maintenance that can explain both neuron-dependent tumor progression and also the neural decay associated with GB.

1 December 2012 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
COClara L. Oeste
Clara L. Oeste
ESEsther Seco
Esther Seco
WPWayne F. Patton
Wayne F. Patton
Patricia BoyaPatricia Boya
Patricia Boya
Dolores Pérez-SalaDolores Pérez-Sala
Dolores Pérez-Sala

1 August 2010 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
SMSilvana Mourón
Silvana Mourón
GCGuillermo de Cárcer
Guillermo de Cárcer
ESEsther Seco
Esther Seco
GFGonzalo Fernández-Miranda
Gonzalo Fernández-Miranda
MMMarcos Malumbres
Marcos Malumbres
Angel R. NebredaAngel R. Nebreda
Angel R. Nebreda
RINGO/Speedy proteins are direct activators of Cdk1 and Cdk2 that have no sequence homology to cyclins. We have characterized the role in cell-cycle progression of a new human member of this protein family referred to as RINGO C. We show that siRNA-mediated knockdown of RINGO C results in premature mitotic exit with misaligned chromosomes, even in the presence of microtubule poisons. Time-lapse-microscopy experiments suggest that RINGO C is involved in the spindle-assembly checkpoint (SAC). Consistent with this idea, RINGO-C-depleted cells show impaired recruitment of the SAC components Mad2, Bub1 and BubR1. As the checkpoint is overridden, cells display defective chromosome segregation, which leads to an increased number of micronuclei and binucleated structures. Intriguingly, we found that RINGO C can associate with the mitotic kinase Aurora B, and downregulation of RINGO C produces mislocalization of the active form of Aurora B in prometaphase. Taken together, our results indicate a role for RINGO C in the mitotic checkpoint, which might be mediated by defective recruitment of SAC components and deregulation of the activity of Aurora kinase B.